Philips issues correction for Trilogy Evo Platform ventilators
By HME News Staff
Updated 10:32 AM CDT, Mon April 20, 2026
AMSTERDAN – Philips has issued a correction for Trilogy Evo Platform Ventilators, according to the U.S. Food and Drug Administration (FDA). The company has identified issues related to the use of prohibited non-pneumatic nebulizers and the obstruction alarm timing. As of March 6, it has reported three serious injuries and no deaths associated with these issues. Philips has sent affected customers a letter recommending that they:
- Update all Trilogy Evo Platform ventilators with software version 1.05.15.00.
- Stop all use of non-pneumatic nebulizers with Trilogy Evo Platform ventilators.
- Review the latest version of the user manual addendum.
Durable medical equipment (DME) and home care customers in the U.S. with adverse reactions, quality problems, or questions about this recall should contact Philips at 1-800-345-6443, press option 2 for repair and then option 1.
Comments